Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Diltiazem hydrochloride 180 mg, 240 mg, 300 mg Note: Not to be marketed as substitutable for any other slow release diltiazem tablets as if the two (2) products were bioequivalent. Tablet, slow release Fering AB, Malmo, Sweden Dilzem SR Nicotine 2 mg, 4 mg Chewing gum Fertin Laboratories S/A., Vejle, Denmark Nicotinell (Mint Flavour) Nicotine 2 mg, 4 mg Chewing gum Fertin Laboratories S/A., Vejle, Denmark Nicotinell (Original Flavour) Cyclosporin A 100 mg/mL in 50 mL Solution, oral Sandoz Pharma Limited, Basle, Switzerland Sandimmun-Neoral Cyclosporin A 25 mg, 50 mg, 100 mg Capsules Sandoz Pharma Limited, Basle, Switzerland and R P Scherer GmbH., Eberbach/Baden, Germany Sandimmun-Neoral Dated this 18th day of March 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.